Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001027193 | SCV001189709 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | The c.8111delCins30 pathogenic mutation, located in coding exon 17 of the BRCA2 gene, results from the deletion of one nucleotide and insertion of 30 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.S2704*). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |